生物注射器市场预计在 2023 年至 2031 年期间的复合年增长率为 10.3%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。
报告按应用(肿瘤学、心脏病学、自身免疫、疼痛管理、其他)进行细分。报告进一步根据最终用户(医院药房、零售药房、药店、其他)进行分析。全球分析进一步细分为区域和主要国家。报告以美元为单位提供上述分析和细分的价值。
报告目的
Insight Partners 的《生物注射器市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:
- 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
- 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
- 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。
生物注射器市场细分
应用
- 肿瘤学
- 心脏病学
- 自身免疫
- 疼痛管理
- 其他的
终端用户
- 医院药房
- 零售药店
- 药店
- 其他
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
生物注射器市场增长动力
- 慢性病发病率不断上升:糖尿病、类风湿性关节炎和癌症等慢性病发病率不断上升,对生物注射器的需求也随之增加。生物注射器可以准确、高效地注射生物药物,从而显著提高患者对治疗的依从性,最大限度地减少重复住院的需要,提高全球对生物注射器的接受度。
- 生物药物的进步:从单克隆抗体到基因疗法,生物药物疗法的兴起推动了对实用药物输送系统的需求。生物注射器对于这些复杂、昂贵的药物的给药至关重要;自行给药将节省医疗资源,更不用说让患者在家中就能获得精确且可预测的剂量。
- 注射装置的技术创新:先进的生物注射器配备了先进的智能技术、无线连接和易用性,可提高患者的依从性和治疗效果。这些创新可以更好地控制剂量,确保最大限度地减少人为错误,并实时监测患者的依从性。所有这些都会促进市场增长。
生物注射器市场未来趋势
- 个性化医疗和自我给药:个性化医疗正在增加生物疗法的自我给药。生物注射器采用人体工程学设计、预装注射器和自动注射系统,以患者为中心,方便自我给药治疗,使患者能够在家中轻松进行适当的医疗治疗,同时保持更好的依从性。
- 数字医疗解决方案:生物注射器越来越多地与数字工具集成,例如通过移动应用程序跟踪注射、提醒遵守情况和远程监控。因此,这些技术使患者和医疗保健提供者能够访问实时信息,进一步实现患者管理,优化治疗结果,并为医疗保健系统提供可用于临床决策的有用信息。
- 技术发展和标准化:为了促进生物注射器市场的增长,监管机构努力在设备安全性和有效性方面制定标准化规范。更严格的监管协议将迫使制造商确保更高质量的安全有效的设备,增强市场信心并加快产品审批速度,从而推动市场进一步扩张。
生物注射器市场机会
- 新兴市场报销政策改善:鉴于发展中地区,亚太地区和拉丁美洲是生物制剂注射器存在机会的地区。随着慢性病确诊病例的增加,对高效药物输送的需求预计将会增加。生物制剂报销政策的改善可能会为新兴经济体的主要制造商带来机会。
- 政府干预:政府部门越来越多地参与制定药品给药标准规范和高端生物药定价框架,这可能为国内制造商带来机遇。这主要适用于慢性病管理,其中改善患者的治疗效果是公共参与者和药品监管机构考虑的关键因素之一。
生物注射器市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响生物注射器市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的生物注射器市场细分和地理位置。
- 获取生物注射器市场的区域特定数据
生物注射器市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | XX 百万美元 |
2031 年市场规模 | XX 百万美元 |
全球复合年增长率(2023 - 2031) | 10.3% |
史料 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按应用
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
生物注射器市场参与者密度:了解其对业务动态的影响
生物注射器市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在生物注射器市场运营的主要公司有:
- 罗氏
- 雅培
- 肖特
- 尼普罗
- 欧皮
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 获取生物注射器市场顶级关键参与者概览
主要卖点
- 全面覆盖:报告全面涵盖了生物注射器市场的产品、服务、类型和最终用户的分析,提供了整体概况。
- 专家分析:报告基于对行业专家和分析师的深入了解而编写。
- 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
- 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。
因此,生物注射器市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Real-Time Location Systems Market
- Aerosol Paints Market
- Mice Model Market
- Underwater Connector Market
- Third Party Logistics Market
- Saudi Arabia Drywall Panels Market
- Electronic Toll Collection System Market
- Integrated Platform Management System Market
- Educational Furniture Market
- Biopharmaceutical Tubing Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The biologic injector market majorly consists of players such AbbVie, Amgen, BD among others
Asia-Pacific region is likely to witness the fastest growth rate during the forecast period.
Self-administration of biologic therapies is likely to remain the key trend during the forecast period.
The market drivers include growing incidence of chronic conditions like diabetes, rheumatoid arthritis, and cancer and biotechnology and expansion of biologic drug therapies, such as monoclonal antibodies and gene therapies are driving the biologic injector market
North America dominated the biologic injector market in 2023
The biologic injector market is estimated to grow with a CAGR of 10.3% from 2023 to 2031
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. Roche
2. Abbott
3. Schott
4. Nipro
5. Ompi
6. Becton and Dickinson & Co.
7. Bayer AG
8. Pfizer, Inc.
9. Bristol-Myer Squibb
10. Novartis International AG
11. Samedan Ltd
12. E3D Elcam Drug Delivery Devices
13. Zealand Pharma A/S (Valeritas, Inc.)
14. Ypsomed AG,
15. Tandem Diabetes Care, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.